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Lymphotoxins and Cytomegalovirus
Cooperatively Induce Interferon-,
Establishing Host-Virus De´tente
and survival pathways. Members of the TNF family that
regulate cell viability may provide strong selective pres-
sure for viruses to evolve counterstrategies. In this re-
gard, TNF and lymphotoxin (LT)- induce antiviral activ-
ity to a broad range of viruses in tissue culture by causing
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2 Allimmune, Inc. premature death of the virus-infected cell, thus limiting
San Diego, California 92121 the production of new virions (Wong and Goeddel, 1986).
3 Department of Pediatrics TNF and LT, along with LT and LIGHT, define a
University of Alabama School of Medicine core group of ligands within the larger TNF superfamily
Birmingham, Alabama 35294 that bind four cognate cell surface receptors with dis-
4 Departments of Immunology and Molecular Biology tinct, but significant, overlapping specificity. TNF and
Division of Virology LT, as homotrimers, bind the same two receptors,
The Scripps Research Institute TNFR1 (55–60 kDa, CD120a) and TNFR2 (75–80 kDa,
La Jolla, California 92037 CD120b). TNFR1 contains a death domain that couples
the receptor to caspase 8 via the adaptors TRADD and
FADD leading to apoptosis (reviewed in Wallach et al.,
Summary 1999). The related death domain receptors, Fas and
TRAIL receptor (TRAIL-R) types 1 and 2, induce apopto-
Tumor necrosis factor (TNF)-related cytokines regu- sis via the death domain adaptor FADD (Bodmer et al.,
late cell death and survival and provide strong selec- 2000). LT assembles with LT to form the LT12 het-
tive pressures for viruses, such as cytomegalovirus erotrimer that binds exclusively to the LTR. The LT-
(CMV), to evolve counterstrategies in order to persist related ligand, LIGHT, engages the herpesvirus entry
in immune-competent hosts. Signaling by the lympho- mediator (HVEM or HveA) and signals through the LTR.
toxin (LT)- receptor or TNF receptor-1, but not Fas HVEM binds LT but not to either TNF or LT hetero-
or TRAIL receptors, inhibits the cytopathicity and repli- trimer (Mauri et al., 1998). LTR, TNFR2, and HVEM
cation of human CMV by a nonapoptotic, reversible use members of the TRAF family of zinc RING finger
process that requires nuclear factor B (NF-B)- adaptors to propagate signals that activate transcription
dependent induction of interferon- (IFN-). Efficient factors, including nuclear factor-B (NF-B) and AP1
induction of IFN- requires virus infection and LT sig- (Wallach et al., 1999), which regulate expression of in-
naling, demonstrating the need for both host and viral flammatory and cell survival genes. The LTR can also
factors in the curtailment of viral replication without induce a slow apoptotic death of some tumor lines,
cellular elimination. LT-deficient mice and LTR-Fc which appears to involve TRAF3 (Force et al., 1997).
transgenic mice were profoundly susceptible to mu- Although the complexities of receptor cross-utilization
rine CMV infection. Together, these results reveal an by this group of LT-related ligands suggest functional
essential and conserved role for LTs in establishing redundancy, gene deletion studies in mice have re-
host defense to CMV. vealed unique and cooperating roles for these cytokines
in the immune response. The LT-LTR system is es-
Introduction sential for the differentiation of specific progenitor cells
involved in the development of lymphoid organs and
Herpesviruses establish life-long infections in their natu- innate effector cells, NK and NK-T (Fu and Chaplin, 1999;
ral host with little or no disease manifestations; however, Elewaut et al., 2000). TNF is crucial for inflammatory
this benign course of infection depends on active resis- responses but cooperates with LT in the homeostasis
tance by innate and specific immune defenses, as dem- of splenic architecture and formation of germinal centers
onstrated by their striking virulence upon immunosup- during response to antigen (reviewed in Fu and Chaplin,
pression. This pattern of infection is characteristic of a 1999). LIGHT and HVEM are currently less well under-
viral pathogen that has evolved the means to coexist stood, but LIGHT can interfere with herpes simplex virus
with its natural host. Herpesviruses, such as cytomega- entry (Mauri et al., 1998) and may play a role in lympho-
lovirus (CMV), use a variety of strategies that target host cyte activation and tumor immunity (Tamada et al.,
defenses, from the disruption of antigen-processing 2000).
pathways to the modulation of cytokines (Tortorella et
This group of TNF-related cytokines provides a poten-
al., 2000), all of which may contribute to the success of
tially powerful selective force that may direct evolution
CMV in establishing coexistence. Several members of
toward virus-host coexistence. Recent evidence shows
the tumor necrosis factor (TNF) superfamily of mem-
that several herpesviruses specifically target TNF-relatedbrane-anchored cytokines play crucial roles in the innate
cytokine systems. These virus-encoded genes includeand adaptive immune responses by regulating cell death
envelope glycoprotein-D of herpes simplex virus (-her-
pesvirus), which acts as a competitive antagonist of the
5 Correspondence: carl_ware@liai.org
LIGHT-HVEM binding interactions (Mauri et al., 1998);6 These authors contributed equally to this work.
the latent membrane protein-1 of Epstein-Barr virus7 Present address: Scottish Centre for Genomic Technology and
(-herpesvirus), which usurps the signaling adaptorsInformatics, University of Edinburgh, Summerhall, Edinburgh, EH9
1QH, Scotland. TRAF and TRADD (Farrel, 1998); vFLIP of equine -her-
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pesvirus, an antagonist of caspase 8 activation that
blocks apoptosis by Fas and TRAIL-R (Tschopp et al.,
1998); and the UL144 open reading frame of human CMV
(-herpesvirus; HCMV), an ortholog of HVEM and TRAIL-
R2 (Benedict et al., 1999). We reasoned that these di-
verse molecular links reflect a specific evolutionary his-
tory between the LT/TNF cytokine system and different
subtypes of herpesviridae. These observations prompted
us to ask whether LT/TNF-related cytokines can elicit
resistance to herpesvirus infection, perhaps providing
selective pressures directing the evolution of viral coun-
termeasures.
Here we show that signaling by the LTR and TNFR1,
but not by Fas or TRAIL-R, initiates a potent nonapo-
ptotic antiviral activity that inhibits cytopathicity and
replication of HCMV in diploid fibroblasts. Furthermore,
the efficient induction of interferon- (IFN-) depends on
both HCMV infection and LT receptor signaling, which
demonstrates a mutual dependence on both host and
virus factors to establish a state of coexistence. Al-
though mouse CMV (MCMV) and HCMV are genetically
distinct, LTs also appear to play a fundamental role in
host defense against MCMV, as revealed by the pro-
found susceptibility of LT-deficient mice and LTR-Fc
transgenic mice to MCMV infection. Together, these re-
sults reveal a previously undisclosed mechanism for
controlling a -herpesvirus infection.
Figure 1. Inhibition of HCMV-Induced Cytopathicity by LTs and
LIGHT
Results
NHDFs were infected with HCMV at an MOI of 0.01, and various
purified recombinant cytokines were added to medium at a final
Inhibition of HCMV by LTs and LIGHT concentration of 5 nM. After culture for 7 days, the cytopathic effect
was visualized by light microscopy (20 magnification).The replication cycle of HCMV in normal human diploid
(a) NHDF infected with virus in medium or in medium with LT (b),fibroblasts (NHDF) reaches completion after72 hr. At a
LT with TNFR1-Fc (25 g/ml) (c), mutant LTY108F (d), LIGHT (e),low multiplicity of infection (MOI  0.1), HCMV infection
mutant LIGHTG119E (f), and LT12 (g).appears in focal areas of cytopathicity typified by cell
rounding and detachment, which spreads throughout
the culture by days 6–7 (Figure 1a). The addition of LT, the agonistic anti-TNFR1 mAb H398 also inhibited
LT12, or LIGHT to the cultures completely inhibited the
HCMV replication (data not shown). Consistent with the
cytopathic effect of HCMV (Figures 1b, 1e, and 1g). The
reduction in cytopathicity and viral protein expression
anti-HCMV activity of LT was neutralized when excess
mediated by these cytokines, the production of infec-soluble decoy receptor TNFR1-Fc was added (Figure
tious virus was also significantly reduced (Figure 2c).1c). Furthermore, point mutations in LT (LTY108F)
Obvious cell death was not detected in NHDF treated(Williams-Abbott et al., 1997) or LIGHT (G119E) (Rooney
with LTs whether infected with HCMV or not. Dermalet al., 2000b), mutations that disrupt binding to their
fibroblasts express receptors for FasL and TRAIL and,specific receptors TNFR1 and LTR, abolished the in-
in the presence of cycloheximide, undergo apoptosishibitory action of these cytokines (Figures 1d and 1f).
following treatment with pM levels of ligand (C.A.B. andCytokine-mediated inhibition was equivalent whether
C.F.W., unpublished observations). Surprisingly, FasLadded at the time of virus infection or several hours after
and TRAIL were unable to reduce virus production (Fig-virus adsorption, indicating that they did not disrupt
ure 2c) or to inhibit virus-protein expression and cyto-attachment or entry of HCMV (data not shown).
pathicity (data not shown), indicating that the antiviralTo assess the effect of LT, LT12, and LIGHT on
effect is specific to LIGHT and LTs in this model. To-HCMV protein expression, both the major immediate
gether, these results suggest that the mechanism ofearly protein (IE1/pp72) and the late tegument protein
blocking virus spread was probably not by inducingpp28 were analyzed by Western blot (Figure 2a). LT12
death of infected cells.and LIGHT showed similar relative antiviral activity (IC50
for inhibition of pp28 expression of 1 and 0.4 nM,
Nonapoptotic and Reversible Effect of LT and LIGHTrespectively), whereas LTwas40-fold more effective
on HCMV Replication(IC500.01 nM; Figure 2b), which is consistent with the
Although cell death or cytopathic effects were not ob-higher receptor binding affinity of secreted LT com-
served in HCMV-infected fibroblasts treated with LTs orpared with the normally membrane anchored LT12
LIGHT, some expression of IE1 was always detectableand LIGHT (Rooney et al., 2000b). Activation of the LTR
7 days postinfection (Figures 2a and 3a), even at highvia addition of an agonistic polyclonal IgG elicited the
concentrations of cytokine that completely block infec-inhibitory effect on HCMV protein expression (Figures
tious virus production (Figure 3b). This suggests that2a and 2b), indicating that this receptor mediated the
antiviral effects seen with LT12 and LIGHT. Similarly, receptor signaling may block viral spread by inhibiting
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Figure 3. The Antiviral Effect of LT Is Reversible
(a) NHDFs were infected with HCMV at an MOI of 0.01 and cultured
with LT (1 nM; 	). After 7 days, the medium was replaced with
fresh medium without LT
, and virus replication was allowed to
proceed for an additional 7 days. Cells were harvested at the indi-
cated time postinfection and virus protein expression analyzed by
Western blot (IE1, gB, gH, and pp28). The “no LT” lanes represent
HCMV proteins at 7 or 14 days in the absence of LT.
(b) HCMV titers ( SD) were measured every 24 hr after infection of
NHDF (MOI  0.01) for cells infected in the absence of LT (square),
or with LT for the initial 7 days and then was removed for days
8–14 (triangle).
state. To test this hypothesis, NHDFs infected with
HCMV and treated with LT for 7 days were washed
and then supplemented with medium without cytokine
for an additional 7 days. The immediate early protein 1
(IE1/pp72) and viral glycoproteins gB and gH (early and
early-late expressed genes, respectively) (Chambers et
Figure 2. Analysis of HCMV Protein Expression in LT-Treated Cells al., 1999) could be detected by Western blot during the
(a) HCMV-infected fibroblasts (MOI  0.01) were treated with indi- initial 7 days of infection in the presence of LT when
cated purified cytokines, and cells were harvested 7 days later for
no cytopathicity or virus production was seen. However,analysis of the major immediate early I protein (IE1) or late tegument
expression of the true late protein pp28 (Kerry et al.,protein (pp28) by Western blot. M, mock; V, virus with no cytokine
1997) was undetectable (Figure 3a). This level of proteinadded.
(b) The percentage of maximal protein expression in the Western most likely represents expression in cells initially in-
blot was calculated as a ratio of the pp28 band density in cytokine fected at low MOI. A vigorous reemergence of viral pro-
treated cells to cells infected with virus in the absence of cytokine. tein expression (Figure 3a) with high levels of pp28,
(c) Infectious virus production ( SD) was measured in supernatants
concurrent with the release of infectious virions (Figurecollected from NHDF infected with HCMV alone or infected in the
3b), occurred after this initial 7 day period when thepresence of LT (0.1 nM), LT12 (1 nM) or LIGHT (1 nM),or FasL
culture was replaced with fresh medium-lacking cyto-(12 nM) or TRAIL (12 nM). Cytokine dose response curves and viral
titers were performed at least three times; data from a single repre- kine. Thus, the block to HCMV appears to be late in the
sentative experiment are shown. replication cycle based on Western blot analysis of these
representative viral proteins and the short lag time be-
fore cytopathicity (24 hr) and the appearance of virusgene expression downstream of the immediate early
genes. If this is the case, then cytokine-treated cells in the culture supernatant (48 hr) after removal of cyto-
kine. LT12, anti-LTR antibodies, and LIGHT similarlymay harbor HCMV genome in a restricted expression
Immunity
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inhibited HCMV (data not shown). Together, these re-
sults demonstrate that the antiviral effect of LTs and
LIGHT is reversible and does not involve death of virus-
infected cells.
NF-B but Not TRAF3 or FADD Is Necessary
for LT/LIGHT-Mediated Anti-HCMV Activity
The LTR and TNFR1 are capable of activating both
apoptotic and nonapoptotic signaling pathways that can
be distinguished by introducing dominant-negative (dn)
mutants of key signaling molecules. Mutant signaling mol-
ecules were introduced into NHDF with retroviral vectors
containing dominant-acting forms of IB, TRAF3, FADD,
or a control empty vector (LXSN). The IBmutant (IBM)
contains two point mutations at serine 32 and 36 to
alanine that deletes the critical phosphorylation sites
targeted by cytokine-activated serine kinases (Van An-
twerp et al., 1996). When introduced into NHDF, IBM
protein cannot be phosphorylated and degraded by the
ubiquitination pathway, thus retaining NF-B in its latent
cytoplasmic state, which in turn prevents nuclear trans-
location and transcriptional activation of NF-B target
genes such as intercellular adhesion molecule-1 (ICAM-1;
Figure 4a). The IBM-expressing fibroblasts when
compared with control vector transduced cells were re-
fractory to the antiviral effects of LTs and LIGHT, as
detected by viral protein expression (Figure 4b) or virus
production (Figure 4c). Importantly, the IBM did not
significantly alter HCMV replication in the absence of
cytokine. In contrast, the TRAF3 dn mutant, which can
inhibit LTR-induced death in HT29 carcinoma cells, but
not NFB activation (Force et al., 2000; Rooney et al.,
2000b), did not block the antiviral effect of either LT12
or LIGHT. Surprisingly, the FADD dn mutant, which de-
letes the death effector domain required for caspase 8
recruitment to TNFR1 and Fas, actually enhanced the
effect of LT but also partially diminished virus replica-
tion in the absence of cytokine. These results demon-
Figure 4. NFB, but Not TRAF3 or FADD, Is Critical for Anti-HCMV
Signaling by TNFRI and LTR
(a) NHDF were transduced with retroviral vectors expressing either
a dn IB mutant (IBM), TRAF3.11 and 7 mutants, FADD-dn
(F-dn), or empty vector (LXSN). NHDF-IBM cells were treated with
TNF or LT (1 nM) for 24 hr, and ICAM-1 expression was measured
by flow cytometry (LXSN, upper 2 panels; IBM, lower 2 panels).
Cell lysates were prepared and analyzed by Western blot for expres-
sion of IB, FLAG-tagged TRAF3.11 and 7, and FADD-dn mu-
tants. For the IB degradation assay, cells were either mock treated
(lanes 1 and 4) or were treated with 1 nM TNF (lanes 2 and 5) or
LT (lanes 3 and 6) in the presence of 10 g/ml cyclohexmide for
4 hr. C, control LXSN cell lysate.
(b) NHDF-expressing dn mutants were compared with control cells
(LXSN) for the ability of LT, LT12, or LIGHT to inhibit expression
of IE1 and pp28 at 7 days by Western blot. Blots were reprobed
with an anti--actin (A) antibody. Concentrations of cytokines or
antibodies added to the culture medium were: LIGHT and LT, serial
10-fold dilution starting at 10 nM; LT12, 5 nM,1 nM, 0.1 nM, and
0.01 nM.
(c) Supernatants were collected from HCMV-infected NHDF cell lines
treated with cytokine (LT, 0.1 nM; LT12, 1 nM; LIGHT, 1 nM) for
7 days and then analyzed for plaque-forming units (PFUs). HCMV
PFUs were determined in quadruplicate, and SDs are contained
within the symbols. Western blots and titers were performed at least
three independent times, and representative results are shown.
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strate that anti-HCMV signaling mediated by both
TNFR1 and LTR requires activation of NF-B and fur-
ther confirm that inhibition of HCMV replication does
not involve apoptosis of infected cells.
Interferon- Mediates LT and LIGHT-Dependent
Antiviral Activity
Supernatant from LT-treated HCMV infected fibro-
blasts, but not from cells treated with LT or virus alone,
was capable of transferring antiviral activity to newly
infected cells (Figure 5a). However, neutralization of LT
in these supernatants by TNFR1-Fc failed to block the
antiviral activity as measured by IE1 protein expression
(Figure 5a). This result suggested that a secondary medi-
ator was responsible for the antiviral activity induced
by LTs, implicating type I interferon as a candidate.
Neutralizing antibodies to IFN- added to the medium
along with TNFR1-Fc ablated the transfer of antiviral
activity (Figure 5a). Inclusion of anti-IFN--neutralizing
antibodies on initial treatment of HCMV-infected cells
with LT also reversed the block to viral gene expression
(Figure 5b) and virion production (Figure 5c). Anti-IFN-
showed very minimal (5% compared with anti-IFN),
but consistent, neutralizing activity; anti-IFN-was with-
out effect (Figure 5b). Additionally, anti-IFN- was able
to block the antiviral activity of LIGHT or LTR agonistic
antibodies (data not shown), suggesting a similar signal-
ing mechanism is initiated by both LTR and TNFR1.
A high-level induction of IFN mRNA was observed
only in NHDF that were both infected with HCMV and
treated with LT (Figure 6a), LIGHT, or LT12 (Figure
6b). The level of IFN message increased proportional
to the amount of infectious virus, suggesting that the
production of IFN occurred in virus-infected cells (Fig-
ure 6a). The induction of IFN was rapid, peaking at 4–6
Figure 5. The Anti-HCMV Activity of LT Is Mediated through thehr after infection, whereas trace levels of IFN mRNA
Induction of IFN-were detectable at 8–10 hr after infection (Figure 6c).
(a) Medium from NHDF infected with HCMV (MOI  0.01; lanes 1,Treatment of NHDF with polyI:C, a potent IFN inducer,
4, and 7), treated with 1 nM LT (lanes 2, 5, and 8), or infected and
stimulated IFN- and IFN- mRNA in the absence of LTs treated with LT (lanes 3, 6, and 9) was collected after 2 days and
or virus. IFN-was not detected in uninfected cells treated transferred to NHDF freshly infected with HCMV (MOI  0.01). The
with LTs but was minimally induced by HCMV alone; how- medium from infected cells was untreated (lanes 1–3) or treated
with 25 g/ml TNFR1-Fc (lanes 4–6) or 25 g/ml TNFR1-Fc andever, this level of IFN- induction with virus alone was
500 units anti-IFN- neutralizing antibody (lanes 7–9). Cells werenot sufficient to restrict CMV replication (Figure 5).
harvested 7 days later and analyzed for IE1 expression by WesternQuantitative real-time reverse transcription-polymerase
blot.
chain reaction (RT-PCR) revealed an induction of IFN (b) NHDF cells were infected with HCMV (MOI  0.01) and, at the
mRNA 48- to 103-fold (mean  77  26; n  4) above time of infection, were treated with LT (1 nM, except for lane 2), anti-
the level seen with virus alone (Figure 6d). NHDF-IBM IFN-, or anti-IFN- neutralizing antibodies. Cells were harvested 7
days after infection and analyzed for expression of IE1 by Westernhad significantly reduced levels of IFN-mRNA after expo-
blot. M, mock infected cells; lane 1, LT alone; lane 2, virus only.sure to HCMV and LT (8.6-fold induction vs. 103-fold in
Cells were treated with 1 nM LT (lanes 3–9). Dose titration (500LSXN control cells; Figures 6d and 6e), consistent with
units serial diluted 10-fold) with anti-IFN- (lanes 3–5), anti-IFN-
the refractory response to the antiviral effects of LT- (lanes 6–8), or anti-IFN--neutralizing antibodies (25 g/ml; lane 9).
related ligands. Importantly, no difference was seen in (c) Supernatants were collected from NHDF infected with HCMV
the ability of recombinant IFN- to inhibit HCMV replica- alone (none) or infected in the presence of anti-IFN- neutralizing
antibody (IFN, 500 U), LT (1 nM), LT plus neutralizing anti-IFNtion in NHDF-IBM cells (data not shown), indicating
(500, 50, and 5 U), or anti-IFN antibody (500 U) as in (b).that NF-B activation is critical for the induction of IFN-
and not for subsequent IFN--mediated antiviral effects.
liver, lung, and salivary glands. Depending on virus dose
and the strain and age of the mice, MCMV can causeLT Is Critical for Host Defense against MCMV
The antiviral activity that LTs exhibit against human CMV death from acute shock at 2–3 days postinfection. How-
ever, the most common course is death at 5–7 days assuggested that these ligands may be conserved across
species. We examined the capacity of LT-deficient mice a result of multiorgan disease and in particular hepatic
failure. LT
/
 mice (C57/BL6 background) were pro-(LT
/
) to respond to infection with MCMV. MCMV repli-
cates in most visceral organs and to high levels in spleen, foundly susceptible to lethal infection with MCMV requir-
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ing100-fold less virus than age-matched C57/BL6 mice
(Figure 7, upper panel). At viral doses 4  104 PFU
(LD50 for LT
/
 mice3  104 PFU) the LT
/
 mice
succumbed at 5–7 days, indicating hepatic failure as
the likely cause of death. Similarly, when high doses of
MCMV (3  106 PFU; LD50 for C57/BL6  2–3  106
PFU) were used to infect C57/BL6 controls; these mice
also died between 5 and 7 days.
LT
/
 mice have defects in the development of pe-
ripheral lymphoid organs and also lack most of their NK
and NK-T cells (Lizuka et al., 1999; Elewaut et al., 2000),
which could account for their susceptibility to MCMV.
However, mice expressing the LTR-Fc decoy as a
transgene, which have a normal complement of lymph
nodes and NK and NK-T cells, were also susceptible to
MCMV compared with transgene negative littermates
(Figure 7, lower panel). This result indicates that the
developmental abnormalities in the LT
/
 mice are not
likely to be responsible for the susceptibility of these
mice to MCMV and implicates LTand LIGHT as poten-
tially critical effector molecules in host defense to
MCMV.
Discussion
The results presented here reveal a molecular mechanism
involved in the establishment of a mutually dependent
coexistence between HCMV and its host cell. Signaling
mediated by LT-related cytokines activate NF-B-
dependent transcription of IFN- only in HCMV-infected
fibroblasts. IFN- then acts to confer cellular resistance
to HCMV blocking viral spread. The mutually beneficial
effect is observed in survival of the infected cell and
inhibition of cytopathicity, with maintenance of the
HCMV genome. The dependence on virus and LT to
induce IFN- may provide, in part, a molecular basis for
the ability of HCMV to establish a state of coexistence,
or de´tente, in immunocompetent hosts.
The HCMV-fibroblast model demonstrates that LTR
and TNFR1 signaling induces a selective antiviral activity
by a nonapoptotic mechanism, which is dependent on
IFN-gene expression. This conclusion is based, in part,
on the reversible nature of the antiviral effect mediated
by LT, neutralization of the antiviral activity with IFN-
antibodies, and the inability of the potent death domain
Figure 6. Signaling through TNFR1 and LTR Induces Transcription receptors, Fas and TRAIL-R, to confer resistance to
of IFN- in HCMV-Infected Cells HCMV. Conclusive evidence on the nonapoptotic nature
(a) NHDFs were infected with HCMV at indicated MOI in medium of the antiviral activity was demonstrated by dominant-
with or without LT (1 nM). acting mutants of the death pathways for TNFR1 (FADD)
(b) NHDF were infected with HCMV (MOI  1) and treated with LT,
and LTR (TRAF3), which failed to block induction ofLT12, or LIGHT (5 and 1 nM each) or treated with cytokine without
the anti-HCMV activity. In contrast, cells that expressvirus infection (5 nM).
(c) NHDF infected with HCMV (MOI  1) plus or minus LT (1 nM) the dominant-acting IBmutant were completely unre-
were harvested at various hours postinfection (hpi) for analysis of sponsive to LTs or LIGHT signaling both at the level of
IFN-, IFN-, and HCMV IE1 expression levels. 	, amplification of ICAM-1 induction and antiviral activity. Previous studies
IFN from NHDF genomic DNA.
(d) Real-time PCR was performed on NHDF-LXSN and NHDF-IBM
cells infected with HCMV (MOI  1) with or without LT (1 nM) in
order to quantify induction of IFN mRNA. Quantification of -actin 3, and 5) and NHDF-IBM (lanes 2, 4, and 6) cells were treated
(A) mRNA was performed in parallel to allow for normalization and with LT (lanes 1 and 2), polyI:C (lanes 3 and 4) or mock infected
calculation of fold difference in IFN- induction. Four independent (M) (lanes 5 and 6). For all panels except (c), cells were harvested
experiments were performed, and the level of IFN in infected cells 4 hr postinfection for isolation of total cell RNA; M, mock infected.
treated with LT was increased by 48- to 103-fold (mean  77  26). NHDF were treated with polyI:C (100 g/ml) with (a and c) or without
(e) NHDF-LXSN or NHDF-IBM cells were infected with HCMV at (e) cycloheximide (10 g/ml) for 4 or 6 (c) hours. All PCR was per-
MOI (1, 0.5, 0.25, 0.125 from left to right) and incubated in medium formed in the linear range excepting panels (a) and (c) (IFN- only)
with or without LT (1 nM). (Right panel) NHDF-LXSN (lanes 1, to allow for detection of low level induction.
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have established that the cell death signaling by TNFR1
or LTR is independent of the activation of NF-B, as
the two pathways bifurcate at the level of the specific
adaptor proteins (Hsu et al., 1996; VanArsdale et al.,
1997). NF-B activation by TNFR1 is achieved by TRADD
or RIP and TRAF2 and other pathways (Wallach et al.,
1999), whereas LTR activation of NF-B is dependent
on TRAF2 or TRAF5, but the LTR also has a TRAF-
independent mechanism for activating this transcription
factor (Force et al., 2000). Although Fas and TRAIL-R
can activate NF-B in certain contexts (Schneider et
al., 1997), they either signal inefficiently in NHDF or are
selectively impaired by HCMV in our system. The finding
that LTR and TNFR1 potently activate NF-B in many
cell types including NHDF, but do not induce IFN- ex-
pression in the absence of virus infection, reveals the
codependence on host and viral factors for IFN- induc-
tion. The IB mutant permits the conclusion that NF-B
is necessary but not sufficient for IFN- induction and
antiviral activity. Interestingly, IFN- induction by TNF
has been observed in fibroblasts, but it requires that the
cells must be stressed by aging in culture (Reis et al.,
1989) and is further evidence that IFN- induction re-
quires cooperating signals.
The IFN- enhanceosome is composed of NF-B
(p50/p65), interferon response factor (IRF)-3 and IRF-7,
Figure 7. Increased Susceptibility of LT
/
 and LTR-Fc Tg MiceATF-2/c-jun, HMGI(Y), and p300/CBP (Maniatis et al.,
to MCMV Infection
1998). As discussed, activation of TNFR1 and LTR can
The upper panel shows groups of LT-deficient mice (n  4 to 6)
induce NF-B, but interestingly, HCMV infection has also infected with MCMV Smith strain at a dose of MCMV, 5  103
been reported to activate NF-B to some extent (Sambu- (square), 4  104 (circle), 8  104 (upside down triangle), 2  105
cetti et al., 1989). Both LTR and TNFR1 signaling acti- (diamond), or 5  105 (triangle) PFU per mouse. Control wild-type
mice (C57/BL6; n  4 per group) were infected with 1  106 (openvates Janus kinase-dependent pathways, which could
square) PFU/mouse and the viability of all mice was monitored dailycontribute to the AP-1 (ATF-2/c-jun) component of the
for 2 weeks.enhanceosome. However, the complete machinery nec-
The lower panel shows groups of LTR-Fc transgenic mice (filledessary for IFN transcription is obviously not activated
symbol) or age- or sex-matched littermate control mice (open sym-
by LTR/TNFR1 signaling; thus, HCMV must provide bol; n  4–6) infected with MCMV at 8  104 (circle) or 2  105
activation of complementary factors, such as IRF-3 (Na- (triangle) PFU per animal. Both LTR-Fc	and control mice infected
varro et al., 1998). Amplification of IFN- transcription with doses at or below 4  104 PFU/mouse demonstrated 100%
survival at 14 days postinfection (data not shown). These experi-through “priming” of cells with low levels of IFN-/ has
ments were repeated on three separate occasions for the LT
/
been reported to be important in generating a robust
and twice for the LTR-Fc	mice.IFN- response, and IRF-3 and -7 are important media-
tors (Sato et al., 2000b). However, IFN- amplification by
stricted state prior to late gene expression in fibroblastsan IRF-7-dependent mechanism is relatively slow (6 hr to
based on detection of immediate early (IE1) and early/initiate) (Sato et al., 2000a) compared with the response
late proteins gB and gH, but not late protein pp28. Thisof fibroblasts treated with LT and HCMV (peak response
restricted pattern of expression induced by LT and IFN-is at 4 hr). This difference suggests that TNFR and/or
in fibroblasts is distinct from what is reported for viralLTR signaling can augment the IFN-/ response in the
latency in cells of monocytic lineage (Kondo et al., 1994).absence of an autocrine “amplification loop” in HCMV-
HCMV infects multiple cell types in vivo, and the avail-infected cells and may be important because HCMV can
able evidence indicates cells of monocytic lineage mayblock IFN signaling pathways (Miller et al., 1999). This
serve as a reservoir of latent virus (Soderberg-Nauclersuggests that LT signaling may be critical for amplifying
et al., 1997b). Treatment of monocytes with IFN- andthe early IFN response to viruses like HCMV. Another
TNF may promote virus reactivation, in contrast to thepossibility is that HCMV has developed a specific strat-
inhibitory effects of LTs in fibroblasts (Soderberg-egy to suppress induction of IFN-, and LTR/TNFR1
Naucler et al., 1997a), highlighting the cell type-specificsignaling overrides the blockade. This hypothesis is sup-
effects of this family of cytokines. Indeed, HVEM, a re-ported by preliminary results indicating that UV-inacti-
ceptor for LIGHT and LT expressed predominantly onvated virus induces IFN- to a greater extent than repli-
cation-competent virus, suggesting that attachment of cells of myeloid/lymphoid origin, could influence viral
gene expression in monocytic cells in a fashion distinctHCMV to cellular receptors may be sufficient to induce
IFN-. This idea gains support in the observations that from TNF. Clearly, the availability of genome-wide tran-
scriptional profiling for CMV (Chambers et al., 1999) maypurified HCMV envelope glycoproteins gB and gH acti-
vate intracellular signaling pathways (Yurochko et al., reveal a clearer definition of genome activity modulated
by LTs and IFN, as well as an exact definition of virus1997).
HCMV replication appears to be arrested in a re- latency.
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Innate antiviral defenses are critical for resistance to reactivation of latent virus, consistent with the control of
MCMV infection (Biron et al., 1999), and this may be acute infection by T cells and prevention of reactivation
true as well for HCMV infection. The IFN- system, in from latency by the redundant action of CD4	T cells and
addition to its direct antiviral control mechanisms, is a B lymphocytes (Lee et al., 2000). In contrast, a reduced
crucial cytokine system produced by the virus-infected virus-specific CD8	 response was observed in LT
/

cell that activates innate defenses mediated by NK cells mice infected with lymphocytic choriomeningitis virus
(Orange and Biron, 1996). NK cells are critical during (Berger et al., 1999) or human herpes simplex virus (Ku-
the acute phase of MCMV infection, whereas T cells maraguru et al., 2001). These results suggest a possible
appear to be important for final resolution of the virus role for LTs in the adaptive immune control of virus
from certain organs in some, but not all, strains of mice persistence.
(Sweet, 1999). NK cell-produced IFN- is important for The finding that LT/LIGHT is important in control-
control of MCMV in the liver (Orange et al., 1995). How- ling both human and MCMV substantiates the idea that
ever, even if IFN- reaches systemic levels, NK cell re- CMV and LTs share significant evolutionary history. Al-
cruitment via chemokines to virus-infected tissue is still though mouse and human CMV have colinear genomes
required for effective defense (Salazar-Mather et al., and display similar replicative programs, the molecular
1998). This finding is consistent with the involvement of mechanisms of immune evasion diverge. This diver-
a cell contact-dependent mechanism, such as expres- gence is observed, for example, at the level of viral
sion of surface LT or LIGHT by activated NK cells, genes targeted at antigen recognition processes as well
for effective defense against MCMV. as effector mechanisms (see Tortorella et al., 2000). The
Ligands that signal via the LT- receptor appear to differences in the details of immune evasion strategies
play a fundamental role in protection against MCMV, as probably reflect the specific adaptations that these vi-
demonstrated by the profound susceptibility of LT
/
 ruses and hosts have evolved to achieve coexistence.
mice and mice expressing the decoy receptor for Nonetheless, the strategies used by CMV are obviously
LT12 and LIGHT. The LTR-Fc Tg is expressed 3 successful as evidenced by the widespread dissemina-
days following birth of the mice and does not cross into tion of CMV in both human and mouse populations
the embryonic circulation or activate complement due (Smith et al., 1993). However, the roles that these elegant
to a mutated Fc region, which results in a less severe evasion mechanisms play in establishing coexistence
phenotype compared to LT
/
 mice (Ettinger et al., remain to be fully elucidated. The mechanisms revealed
1996). Thus, the LTR-Fc should act in vivo as a strict here provide for a clearer understanding of host-virus
antagonist of LT12 and LIGHT and not through FcR coexistence and may provide for therapeutic opportuni-
or complement elimination of effector cells that may ties to reestablish de´tente with CMV in immune-compro-
display these ligands on the cell surface. The fact that mised hosts.
the LTR-Fc Tg mice have a full complement of lymph
nodes, as well as NK and NK-T cells, supports this idea
Experimental Procedures(Elewaut et al., 2000). However, in common with LT
/

mice, the LTR-Fc Tg mice exhibit disorganized splenic Cells, Virus, Cytokines, and Antibodies
architecture, which is thought to be a homeostatic pro- NHDF (Clonetics, San Diego, CA) were cultured in Dulbecco’s modified
cess mediated by B cells, and lack Peyer’s patches, a Eagle’s medium (GIBCO-BRL, Grand Island, NY) supplemented with
10% fetal bovine serum. HCMV strain AD169 (American Type Culturelate event involved in organogenesis (Fu and Chaplin,
Collection, Rockville, MD) stocks were prepared and quantified by1999). Effector functions such as induction of integrins
limiting dilution plaque formation assay on NHDF. Purified recombinantor chemokines may be absent (Luther et al., 2000). Another
soluble LIGHT (Rooney et al., 2000b), mutant LIGHTG119E (Rooney etobservation pointing to a specific role for LT and
al., 2000b), and LTY108F (Williams-Abbott et al., 1997) were purified
LIGHT is the finding that TNFR1-deficient mice are resis- as described, and LT and LT12 were gifts from Jeff Browning
tant to MCMV but also have a disorganized splenic archi- (Biogen, Inc., Cambridge, MA) (Browning et al., 1996). Anti-LTR (goat)
tecture and lack Peyer’s patches (Fleck et al., 1998). antibodies and decoy receptors TNFR1-Fc and LTR-Fc were purified
as described (Rooney et al., 2000a). IFN-, IFN-, and their specificThis result indicates that signaling by TNFR1 through
antibodies (sheep polyclonal) were from Research Diagnostics (Flan-its two known ligands, LT and TNF, is insufficient for
ders, NJ), and Fas ligand and TRAIL were from Alexis Biochemicalshost resistance to MCMV. The inability of the LIGHT-
(San Diego, CA). ICAM-1 was detected with mAB 2146 (Chemicon,LTR pathway to provide protection against MCMV in
Temecula, CA) by flow cytometry (FACS Caliber; Becton-Dickinson,
the LT
/
 mice may be due to the absence of LIGHT Mountain View, CA) and staining with goat anti-mouse IgG conjugated
and LT-expressing NK cells. Together, these genetic to R-phycoerythrin. Anti-IB (rabbit polyclonal Ab; Upstate Biotech,
models implicate the LT12/LIGHT-LTR systems as Lake Placid, NY) and anti-FLAG epitope (Sigma, St. Louis, MO) were
used in Western blotting as described (Benedict et al., 1999). Anti-functionally relevant cytokines for resistance to MCMV.
HCMV monoclonal antibodies IE1 (clone 63 and 27), pp28, gB, andNK cell production of LT or LIGHT could play a role in
gH were prepared as described (Sanchez et al., 1998).the induction of IFNs, chemokines, or integrins essential
for host defense to CMV. In this regard, early host de-
fense mechanisms must be sufficient to attenuate the Virus Infection
NHDFs were seeded into 96-well plates at 1  104 cells/well or 1.5 initial infection in order for adaptive immunity to develop.
105 cells in 12-well plates and infected the following day with HCMVLT
/
 mice are capable of resisting some other viruses
(MOI 0.01). Virus was allowed to adsorb for 2 hr at 37C; cells wereand thus are not globally impaired in adaptive defenses,
then washed twice and cultured in medium with indicated reagents.
although the magnitude of the adaptive immune re- For analysis of virus production and protein expression, 12-well cul-
sponse in LT
/
 mice can be somewhat reduced. tures were harvested and centrifuged to collect the cell pellet for
LT
/
 mice cleared mouse -herpesvirus-68 with de- protein analysis by Western blotting as described (Benedict et al.,
1999), and the supernatant was assayed for infectious virus by plaquelayed kinetics but were fully competent at preventing
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assay. To control for equal protein loading, the blots were reprobed to six mice per virus dose and the mice monitored daily for morbidity
and mortality over a period of 14 days.with an antibody to human -actin (MAB810; Chemicon).
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